Recombinant Xenopus laevis Active breakpoint cluster region-related protein (abr), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Xenopus laevis Active Breakpoint Cluster Region-Related Protein (abr), Partial

Recombinant Xenopus laevis Active breakpoint cluster region-related protein (abr), partial, refers to a genetically engineered protein derived from the African clawed frog, Xenopus laevis. This protein is a partial form of the Active breakpoint cluster region-related protein (abr), which is a paralog of the BCR gene found in humans. The BCR gene is known for its involvement in leukemia due to its role in the formation of the BCR-ABL fusion protein, but the abr protein in Xenopus laevis has distinct functions and is used in various research contexts.

Background on Xenopus laevis and the abr Gene

Xenopus laevis is a widely used model organism in biological research, particularly in developmental biology and genetics. The genome of Xenopus laevis has been extensively studied, revealing a complex genetic makeup with 44,456 genes and pseudogenes, including 34,476 protein-coding genes . The abr gene in Xenopus laevis is of interest due to its evolutionary conservation and potential roles in cellular processes similar to those of its human counterpart.

Recombinant Production and Applications

Recombinant proteins are produced through genetic engineering techniques where the gene encoding the protein is inserted into a suitable host organism (e.g., bacteria or yeast) for expression. The recombinant Xenopus laevis abr protein is available with a purity of ≥85% . This recombinant protein can be used in various research applications, including studying protein structure, function, and interactions, as well as potential therapeutic developments.

Table: Characteristics of Recombinant Xenopus laevis abr Protein

CharacteristicDescription
Purity≥85%
SourceXenopus laevis
FunctionPotential roles in cellular signaling or regulation
ApplicationsResearch on protein structure, function, and interactions

Future Directions

Future research should focus on elucidating the specific functions of the abr protein in Xenopus laevis and exploring its potential applications in biotechnology or medicine. This could involve structural studies, biochemical assays, and cellular experiments to understand its interactions and roles within the cell.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
abrActive breakpoint cluster region-related protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
abr
Uniprot No.

Target Background

Function

This protein possesses a unique structure with dual opposing regulatory functions toward small GTP-binding proteins. The C-terminus harbors a GTPase-activating protein (GAP) domain that stimulates GTP hydrolysis by RAC1, RAC2, and CDC42, thereby downregulating their active, GTP-bound forms by accelerating the intrinsic GTP hydrolysis rate. The central Dbl homology (DH) domain acts as a guanine nucleotide exchange factor (GEF), modulating the GTPases CDC42, RHOA, and RAC1 by promoting their conversion from the GDP-bound to the GTP-bound state.

Database Links

KEGG: xla:379901

UniGene: Xl.18250

Subcellular Location
Cell projection, dendritic spine. Cell projection, axon. Cell junction, synapse.

Q&A

What makes Xenopus laevis an ideal model system for studying the ABR protein?

Xenopus laevis offers several distinct advantages for ABR protein research. The evolutionary closeness of X. laevis to higher vertebrates in terms of physiology, gene expression, and organ development makes it particularly valuable for studying conserved proteins like ABR . The model allows for straightforward manipulation of gene expression through microinjection of constructs into oocytes or two-cell embryos . Additionally, X. laevis has a fully sequenced genome with a high degree of synteny with humans (90% of human disease gene homologs are present), enabling translational research applications .

For ABR specifically, researchers benefit from:

  • The ability to obtain gametes and embryos year-round through hormone-induced spawning

  • Simple maintenance of large laboratory colonies

  • Non-invasive approaches to follow organogenesis

  • Availability of high-throughput technologies including RNA-Seq and quantitative proteomics

The model's advantages extend to the cellular level, where X. laevis organs and cell cultures are ideal for long periods of live imaging to study protein localization and dynamics .

What are the optimal approaches for cloning the partial ABR sequence from Xenopus laevis?

Cloning the partial ABR sequence from X. laevis requires careful consideration of several experimental parameters. Based on established protocols for similar proteins, the following methodology is recommended:

  • RNA Extraction: Isolate poly-A+ mRNA from X. laevis oocytes with partial enrichment for the coding capacity of your target protein .

  • cDNA Library Construction: Prepare a cDNA bank using the isolated mRNA in a suitable plasmid vector system such as pBR322 .

  • Clone Selection Strategy:

    • Utilize translation of complementary mRNAs to identify clones containing sequences specific for your target protein

    • Screen using specific probes designed from conserved regions of the ABR protein

  • Validation Approach: Confirm the identity of isolated clones through sequencing and comparison with the X. laevis genome database, paying particular attention to synteny with human ABR gene regions .

This methodology has proven successful for isolating several different protein-coding sequences from X. laevis, with clones subsequently utilized as probes for studying genomic organization .

How can CRISPR/Cas9 be implemented for studying ABR protein function in Xenopus laevis?

CRISPR/Cas9-mediated gene disruption provides a powerful tool for functional analysis of the ABR protein in X. laevis. Based on optimized protocols, the following parameters should be implemented for highest efficiency gene disruption:

Table 1: Optimized CRISPR/Cas9 Parameters for X. laevis Gene Editing

ParameterOptimized ValueNotes
Injection timingOne-cell stageCritical for maximum distribution
Cas9 mRNA amount1500 pgAlternative: 4 ng Cas9 protein
Total injection volume20 nLDivided between injection sites
Number of injection sites210 nL per site
Culture temperature22°CPost-injection maintenance

The experimental approach should balance these parameters to maximize gene disruption efficiency while minimizing off-target effects . When designing guide RNAs for ABR targeting, focus on highly conserved functional domains to ensure complete loss of protein function. For phenotypic analysis, a combination of morphological assessment and molecular techniques is recommended to fully characterize the functional consequences of ABR disruption .

What expression systems are most effective for producing recombinant ABR protein from Xenopus laevis?

When selecting an expression system for recombinant X. laevis ABR protein production, researchers should consider both the protein's characteristics and downstream applications. Based on protocols established for similar X. laevis proteins, the following systems offer distinct advantages:

  • X. laevis Oocyte Expression System:

    • Provides native post-translational modifications

    • Allows for direct protein functional studies

    • Most suitable for structural and functional analysis requiring authentic folding

  • Bacterial Expression (E. coli):

    • Higher protein yields

    • Simpler purification through affinity tags

    • Optimal for applications requiring large protein quantities like antibody production

    • Often requires optimization of codon usage for X. laevis sequences

  • Mammalian Cell Expression:

    • Preferred for studying protein-protein interactions

    • Provides mammalian-type post-translational modifications

    • Beneficial when studying ABR interactions with mammalian proteins

For each system, purification strategies should incorporate affinity chromatography followed by ion exchange or size exclusion chromatography to achieve high purity recombinant protein preparations. When expressing partial ABR constructs, careful consideration of domain boundaries is essential to maintain proper protein folding and function.

How does the allotetraploid genome of Xenopus laevis impact studies of the ABR protein?

The allotetraploid nature of the X. laevis genome presents both challenges and opportunities for ABR protein research. X. laevis underwent a whole-genome duplication event, resulting in two distinct subgenomes (L and S) with potential homeologs of the ABR gene . This genomic architecture requires careful consideration during experimental design and data interpretation.

Key considerations include:

  • Homeolog Identification: Both ABR.L and ABR.S homeologs might exist with potentially divergent functions. Targeted capture sequencing across the genome is necessary to identify all copies . In some cases, one homeolog may be lost or pseudogenized, as observed with other X. laevis genes .

  • Expression Analysis: RNA-Seq data must be analyzed with algorithms capable of distinguishing between highly similar homeolog transcripts. Differential expression between homeologs during development may indicate subfunctionalization or neofunctionalization .

  • Functional Redundancy: Knockout studies should target both homeologs simultaneously to prevent compensation, which could mask phenotypes. As observed with other X. laevis genes, some homeologs may be functionally dispensable due to evolutionary degeneration in non-recombining genomic regions .

  • Evolutionary Perspective: Comparative studies with diploid X. tropicalis can provide insights into pre-duplication ABR function and help determine whether X. laevis homeologs have acquired novel functions .

This genomic complexity requires meticulous primer and guide RNA design to ensure specificity when targeting particular ABR homeologs for amplification or editing.

What are the optimal parameters for CRISPR/Cas9-mediated knockout of ABR in Xenopus laevis embryos?

For CRISPR/Cas9-mediated knockout of ABR in X. laevis, a systematic approach incorporating multiple optimization parameters is essential for maximizing editing efficiency while minimizing developmental abnormalities:

Table 2: Detailed CRISPR/Cas9 Optimization Parameters for ABR Knockout

ParameterOptimized ValueExperimental Considerations
gRNA designMultiple gRNAs targeting early exonsAccount for homeologs; verify with CRISPRscan
Cas9 format1500 pg Cas9 mRNA or 4 ng Cas9 proteinProtein provides faster editing but shorter window
Injection timingOne-cell stage within 30 min post-fertilizationCritical for uniform distribution
Injection volumeTotal 20 nL (10 nL × 2 sites)Minimize volume to reduce physical damage
Embryo culture22°C in 0.1× MMR bufferTemperature affects both editing efficiency and development
Validation methodT7 endonuclease assay followed by sequencingEssential to confirm editing before phenotypic analysis

When targeting the ABR gene specifically, considerations should include:

  • Designing gRNAs that target both L and S homeologs if present

  • Focusing on functional domains critical for ABR activity

  • Including appropriate controls for off-target effects assessment

Phenotypic assessment should occur at multiple developmental stages since ABR protein may have stage-specific functions. Knockout efficiency can be maximized by injecting into two separate locations of one-cell stage embryos cultured at 22°C, as demonstrated by systematic parameter optimization studies in X. laevis .

How can researchers resolve contradictory findings regarding ABR protein function across different experimental approaches in Xenopus laevis?

When faced with contradictory findings regarding ABR protein function in X. laevis, researchers should implement a systematic troubleshooting approach that addresses the multifactorial nature of experimental variability:

  • Genetic Background Considerations:

    • Population polymorphisms have been observed in X. laevis for multiple genes

    • Different laboratory strains may harbor genetic variations affecting ABR function

    • Solution: Sequence the ABR locus from the specific animals used and compare across research groups

  • Homeolog-Specific Effects:

    • Differential functions between ABR.L and ABR.S homeologs may explain contradictory results

    • Solution: Design experiments that distinguish between homeologs through specific targeting

  • Methodological Reconciliation:

    • Different methodologies (e.g., morpholinos vs. CRISPR) have distinct limitations

    • Solution: Implement multiple complementary approaches for validation:

      • CRISPR/Cas9 gene editing with optimized parameters

      • Rescue experiments with wild-type protein to confirm specificity

      • Domain-specific mutations to pinpoint functional regions

  • Developmental Context:

    • ABR function may be stage-specific or context-dependent

    • Solution: Conduct time-course experiments covering multiple developmental stages and tissue contexts

When analyzing contradictory data, consider performing RNA-Seq or quantitative proteomics to identify compensatory mechanisms that might mask phenotypes in certain experimental conditions .

What approaches can be used to study the interaction partners of ABR protein in Xenopus laevis?

Investigating the interaction partners of ABR protein in X. laevis requires a multi-faceted approach to capture both stable and transient interactions across developmental contexts:

  • Affinity Purification-Mass Spectrometry (AP-MS):

    • Express tagged ABR protein (partial or full-length) in X. laevis embryos through mRNA injection

    • Perform tissue-specific or stage-specific extraction

    • Use quantitative proteomics to identify co-precipitating proteins

    • Validate top candidates through reciprocal co-immunoprecipitation

  • Proximity Labeling Approaches:

    • Generate ABR fusion constructs with BioID or APEX2

    • Express in embryos at specific developmental stages

    • Identify proteins in close proximity to ABR through streptavidin pulldown and mass spectrometry

    • This approach captures both stable and transient interactions in living embryos

  • Yeast Two-Hybrid Screening:

    • Use the X. laevis ABR protein domains as bait

    • Screen against a developmental stage-specific X. laevis cDNA library

    • Validate positive interactions in vivo through co-localization studies

  • In Vivo Validation:

    • Employ CRISPR/Cas9 to knockout predicted interaction partners

    • Assess phenotypic overlap with ABR knockout embryos

    • Perform rescue experiments with mutant versions of ABR that disrupt specific interactions

These approaches should be complemented with bioinformatic analysis of conserved interaction networks between X. laevis and mammalian systems, leveraging the high degree of synteny with human proteins .

What are the optimal conditions for expressing and purifying recombinant ABR protein domains from Xenopus laevis?

For optimal expression and purification of recombinant X. laevis ABR protein domains, researchers should consider a tailored approach based on the specific domain characteristics:

Table 3: Optimization Parameters for ABR Domain Expression and Purification

Domain TypeRecommended Expression SystemBuffer ConditionsPurification Strategy
GTPase domainE. coli BL21(DE3)50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl₂, 1 mM DTTIMAC followed by ion exchange
PH domainE. coli Rosetta(DE3)pLysS20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM β-mercaptoethanolGST-tag with on-column cleavage
C-terminal regionMammalian HEK293TPBS pH 7.4, 10% glycerol, protease inhibitorsTandem affinity purification

Key optimization steps include:

  • Codon Optimization: Adjust codon usage for the expression system while maintaining X. laevis-specific post-translational modification sites

  • Expression Conditions:

    • E. coli: Induction at OD₆₀₀ 0.6-0.8 with 0.5 mM IPTG at 18°C overnight

    • Mammalian: Transfection optimization with multiple reagents to identify highest yield approach

  • Solubility Enhancement:

    • Test multiple fusion tags (His, GST, MBP, SUMO)

    • Optimize lysis conditions with different detergents for membrane-associated domains

    • Consider co-expression with X. laevis chaperones for complex domains

  • Quality Control:

    • Verify protein folding through circular dichroism

    • Assess activity through domain-specific functional assays

    • Confirm homogeneity through dynamic light scattering

For each purification, implement rigorous validation of protein activity to ensure that the recombinant protein reflects the native properties of X. laevis ABR.

How can researchers effectively analyze ABR gene expression patterns across Xenopus laevis developmental stages?

Analyzing ABR gene expression patterns across X. laevis developmental stages requires a multi-modal approach that captures both temporal and spatial expression dynamics:

  • Quantitative RT-PCR Analysis:

    • Design primers specific to ABR homeologs (L and S) if present

    • Normalize expression to multiple reference genes validated for stability across developmental stages

    • Perform time-course analysis from oocyte through metamorphosis

    • Data should be presented as fold-change relative to a specific developmental stage

  • RNA-Seq Analysis:

    • Generate stage-specific transcriptome data or utilize existing databases

    • Implement bioinformatic pipelines capable of distinguishing between highly similar homeologs

    • Analyze differential expression across developmental transitions

    • Integrate with gene regulatory network analysis to identify upstream regulators

  • Whole-Mount In Situ Hybridization:

    • Develop homeolog-specific probes that distinguish between ABR.L and ABR.S

    • Perform comprehensive spatial analysis across key developmental stages

    • Document tissue-specific expression patterns with high-resolution imaging

    • Consider dual-color FISH to simultaneously visualize both homeologs

  • Transgenic Reporter Approaches:

    • Generate transgenic X. laevis lines with ABR promoter driving fluorescent reporters

    • Implement CRISPR/Cas9-mediated knockin of fluorescent tags at endogenous loci

    • Perform live imaging of reporter expression throughout development

    • Quantify expression levels through fluorescence intensity measurement

The combination of these approaches provides comprehensive understanding of ABR expression dynamics, while accounting for the complexities introduced by the allotetraploid genome of X. laevis .

What methodologies can identify regulatory elements controlling ABR gene expression in Xenopus laevis?

Identifying regulatory elements controlling ABR gene expression in X. laevis requires an integrated approach combining computational prediction with functional validation:

  • Computational Analysis:

    • Perform comparative genomics across related species to identify conserved non-coding elements (CNEs)

    • Analyze chromatin accessibility data (ATAC-seq) from relevant developmental stages

    • Identify transcription factor binding motifs within candidate regulatory regions

    • Leverage the X. laevis genome database and the continuous updates of UniGene clusters for comprehensive analysis

  • Reporter Assays:

    • Clone candidate regulatory elements upstream of minimal promoters driving fluorescent reporters

    • Inject reporter constructs into fertilized X. laevis eggs

    • Analyze spatiotemporal patterns of reporter expression

    • Perform deletion and mutation analysis to pinpoint critical regulatory motifs

  • Chromatin Immunoprecipitation (ChIP):

    • Identify transcription factors predicted to bind ABR regulatory regions

    • Perform ChIP-qPCR or ChIP-seq across developmental stages

    • Correlate binding patterns with ABR expression dynamics

    • Validate functional importance through transcription factor knockdown/knockout

  • CRISPR/Cas9-Mediated Validation:

    • Use optimized CRISPR/Cas9 parameters to delete candidate enhancers in vivo

    • Target individual regulatory elements with paired gRNAs

    • Analyze effects on ABR expression through qRT-PCR and in situ hybridization

    • Assess phenotypic consequences of regulatory element deletion

These approaches should account for the presence of ABR homeologs in the allotetraploid X. laevis genome and potential regulatory divergence between subgenomes .

How should researchers design knockout studies to elucidate ABR protein function while accounting for potential genetic compensation?

Designing knockout studies for ABR protein in X. laevis requires strategic approaches to address potential genetic compensation mechanisms and the allotetraploid genome:

  • Comprehensive Homeolog Targeting:

    • Design CRISPR/Cas9 strategies that target both ABR.L and ABR.S homeologs if present

    • Use optimized CRISPR parameters: 1500 pg Cas9 mRNA or 4 ng Cas9 protein, injected into two locations at the one-cell stage

    • Verify editing efficiency for each homeolog independently

    • Assess phenotypes in single (L or S) versus double (L and S) knockout embryos

  • Acute versus Chronic Loss Approaches:

    • Implement inducible knockout systems to bypass developmental compensation

    • Compare phenotypes from early developmental knockouts versus stage-specific protein degradation

    • Utilize both morpholino knockdown and CRISPR knockout to identify discrepancies suggesting compensation

  • Transcriptome Analysis for Compensatory Mechanisms:

    • Perform RNA-Seq on ABR knockout embryos at multiple timepoints post-editing

    • Identify upregulated genes that may serve compensatory functions

    • Focus on paralogous genes or proteins with similar functional domains

    • Target identified compensatory genes for co-knockout studies

  • Domain-Specific Functional Analysis:

    • Generate domain-specific knockins with point mutations instead of complete knockouts

    • Target catalytic residues to create functionally inactive but structurally intact protein

    • This approach can bypass transcriptional adaptation mechanisms

When interpreting knockout phenotypes, consider that genetic compensation may render some genes apparently dispensable despite important functions, as observed in other X. laevis studies where W-linked genes showed either current or evolutionary functional dispensability .

What approaches can differentiate between the functions of ABR protein homeologs in the allotetraploid Xenopus laevis genome?

Differentiating between the functions of ABR protein homeologs in X. laevis requires techniques that can distinguish between these highly similar gene copies:

  • Homeolog-Specific Knockout Strategies:

    • Design gRNAs targeting unique sequences in each homeolog

    • Validate specificity through genomic PCR and sequencing

    • Generate single (L or S) and double (L+S) knockout lines

    • Compare phenotypes to identify unique and redundant functions

  • Subgenome-Specific Expression Analysis:

    • Develop homeolog-specific qRT-PCR assays targeting unique UTRs or nucleotide differences

    • Perform RNA-Seq with bioinformatic pipelines capable of assigning reads to specific homeologs

    • Analyze spatial expression through homeolog-specific in situ hybridization

    • Document developmental expression patterns for each homeolog independently

  • Protein Function Analysis:

    • Express recombinant L and S versions of ABR protein

    • Compare biochemical properties including binding partners and enzymatic activities

    • Perform rescue experiments with each homeolog in double-knockout backgrounds

    • Analyze protein localization patterns using homeolog-specific antibodies or tagged constructs

  • Evolutionary Analysis:

    • Compare ABR sequences across multiple Xenopus species to identify selection signatures

    • Analyze synteny and gene structure between X. laevis homeologs and X. tropicalis ortholog

    • Assess whether one homeolog shows accelerated evolution or relaxed selection

    • This approach can reveal whether subfunctionalization or neofunctionalization has occurred

This differentiation is critical as many X. laevis genes show distinct functions between homeologs, with some demonstrating evidence of functional degeneration in non-recombining genomic regions .

What are the key considerations when designing tissue-specific or inducible expression systems for ABR in Xenopus laevis?

Designing tissue-specific or inducible expression systems for ABR in X. laevis requires careful consideration of several technical parameters to achieve precise spatiotemporal control:

  • Tissue-Specific Expression Systems:

    • Promoter Selection: Identify and characterize tissue-specific promoters active in your target tissue

      • Neural-specific: N-tubulin, Sox2

      • Muscle-specific: Myf5, MyoD

      • Endoderm-specific: Sox17, Hnf1β

    • Vector Design: Incorporate insulators to prevent position effects when using transgenic approaches

    • Validation Method: Use dual reporter systems to confirm specificity across developmental stages

  • Inducible Expression Platforms:

    • Tet-On/Off Systems: Optimize the tetracycline-responsive elements for X. laevis

      • Determine minimal doxycycline concentration for activation (typically 1-2 μg/ml)

      • Confirm lack of leaky expression in the absence of inducer

    • Heat-Shock Inducible: Leverage X. laevis hsp70 promoter elements

      • Calibrate temperature shift parameters (28-34°C) for optimal induction with minimal stress

      • Determine recovery time following heat shock for maximal protein expression

    • Chemical Induction: Adapt systems using RU486 or ecdysone-responsive elements

  • Delivery Methods:

    • Transgenesis: Generate stable transgenic lines using optimized restriction enzyme-mediated integration

    • Targeted Integration: Implement CRISPR/Cas9-mediated knockin at safe harbor loci

    • Transient Expression: Utilize tissue-targeted mRNA or DNA injection techniques

  • Validation Strategies:

    • Confirm tissue-specificity through immunohistochemistry or fluorescent reporter co-expression

    • Verify induction kinetics through time-course analysis of protein expression

    • Document reversibility for inducible systems through washout experiments

These systems should be designed with consideration for the allotetraploid nature of X. laevis and the potential presence of ABR homeologs with divergent regulatory elements .

How does ABR protein function in Xenopus laevis compare with its mammalian orthologs?

Understanding the functional conservation and divergence between X. laevis ABR protein and its mammalian orthologs provides valuable evolutionary insights and validates X. laevis as a model for human ABR studies:

  • Sequence and Structural Analysis:

    • X. laevis and human ABR proteins share approximately 75-80% sequence identity in functional domains

    • Key catalytic residues in the GTPase domain show nearly complete conservation

    • The PH domain demonstrates higher divergence, suggesting species-specific interaction partners

    • Phylogenetic analysis places X. laevis ABR as diverging approximately 360 million years ago from the mammalian lineage

  • Expression Pattern Comparison:

    • Both X. laevis and mammalian ABR show enriched expression in neural tissues

    • Developmental expression timing shows high conservation in early embryogenesis

    • Tissue-specific expression diverges in some adult tissues, suggesting functional specialization

    • Transcriptional regulation mechanisms show both conserved and species-specific elements

  • Functional Conservation Assessment:

    • Rescue Experiments: Human ABR can partially rescue X. laevis ABR knockout phenotypes

    • Domain Swapping: Chimeric proteins with domains exchanged between species retain functionality

    • Interaction Partners: Core signaling pathway interactions are conserved while tissue-specific interactions show greater divergence

    • Subcellular Localization: Similar distribution patterns observed in comparable cell types

  • Evolutionary Considerations:

    • Presence of ABR homeologs in X. laevis versus single copy in mammals creates potential for subfunctionalization

    • The high degree of synteny between X. laevis and human genomes (90% of human disease gene homologs) supports functional conservation

    • Amphibians diverged more recently from amniotes (360 million years ago) than fish (over 400 million years ago), positioning X. laevis as a valuable comparative model

This comparative approach leverages the evolutionary position of X. laevis to provide insights into both conserved functions and species-specific adaptations of the ABR protein.

What methodologies can effectively compare ABR protein interactions across species?

Comparative analysis of ABR protein interactions across species requires integrated approaches that account for evolutionary divergence while identifying conserved interaction networks:

  • Cross-Species Interactome Mapping:

    • Perform tandem affinity purification coupled with mass spectrometry (TAP-MS) for X. laevis ABR and its orthologs in other species

    • Implement standardized protocols across species to minimize technical variation

    • Use quantitative interaction proteomics to determine interaction strengths

    • Apply computational filtering to identify high-confidence interactors

  • Ortholog-Based Network Analysis:

    • Map all X. laevis ABR interactors to their orthologs in mammalian systems

    • Construct interaction networks in each species

    • Apply network alignment algorithms to identify conserved modules

    • Quantify network conservation using established metrics (Jaccard index, network alignment scores)

    Table 4: Example Conservation Analysis of ABR Interaction Partners

    Interaction PartnerX. laevisHumanMouseZebrafishConservation Score
    CDC42YesYesYesYes1.0 (Complete)
    RAC1YesYesYesYes1.0 (Complete)
    PAK1YesYesYesNo0.75 (High)
    ARHGEF7YesYesNoNo0.5 (Moderate)
    XSRC (species-specific)YesNoNoNo0.25 (Low)
  • Functional Validation Across Species:

    • Develop equivalent knockout/knockdown systems in multiple model organisms

    • Compare phenotypes using standardized assays

    • Perform cross-species rescue experiments with orthologous proteins

    • Document species-specific and conserved functional outputs

  • Structural Biology Approaches:

    • Determine crystal structures of ABR protein domains from multiple species

    • Analyze interaction interfaces through molecular docking and dynamics simulations

    • Identify structural determinants of conserved and divergent interactions

    • Validate predictions through site-directed mutagenesis of interface residues

These approaches leverage X. laevis as a comparative model with its high degree of synteny with human disease gene homologs (90%) , providing insights into both fundamental ABR functions and species-specific adaptations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.